Total planned funding: $484,613,661
Clear active filters
University of Washington
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $92,964,905 |
Namibia | $58,256,731 |
Ethiopia | $50,975,522 |
South Africa | $46,824,613 |
Malawi | $44,252,089 |
Haiti | $42,364,667 |
Botswana | $39,046,913 |
Mozambique | $33,566,820 |
Tanzania | $22,885,365 |
Kenya | $15,759,313 |
Ukraine | $8,767,000 |
Western Hemisphere Region | $5,722,720 |
Asia Regional Program | $5,621,061 |
Côte d'Ivoire | $5,039,003 |
India | $4,990,000 |
Caribbean Region | $4,425,000 |
Vietnam | $1,437,481 |
Guyana | $994,458 |
Angola | $500,000 |
China | $220,000 |
Organizational Types
University | $438,461,900 |
NGO | $37,753,798 |
Implementing Agency | $8,397,963 |
Program Areas
Treatment | $163,397,388 |
Governance and Systems | $126,395,500 |
Prevention | $86,379,776 |
Care | $64,876,671 |
Testing | $33,159,908 |
Management and Operations | $230,000 |
Budget Codes
HTXS: Treatment: Adult Treatment | $150,062,581 |
OHSS: Health Systems Strengthening | $76,269,466 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $52,194,413 |
HVSI: Strategic Information | $40,333,542 |
HBHC: Care: Adult Care and Support | $33,195,087 |
HVCT: Testing: HIV Testing and Counseling | $33,159,908 |
HVTB: Care: TB/HIV | $17,597,333 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,835,411 |
PDTX: Treatment: Pediatric Treatment | $13,334,807 |
HVOP: Sexual Prevention: Other Sexual Prevention | $11,911,346 |
HLAB: Laboratory Infrastructure | $9,792,492 |
HKID: Care: Orphans and Vulnerable Children | $7,732,358 |
PDCS: Care: Pediatric Care and Support | $6,351,893 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,634,115 |
HMIN: Biomedical Prevention: Injection Safety | $321,694 |
HMBL: Biomedical Prevention: Blood Safety | $255,000 |
HVMS: Management and Operations | $230,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $227,797 |
HTXD: Treatment: ARV Drugs | $0 |